Summary
Biogen Inc. announced its third-quarter 2019 financial results on October 22, 2019, via a press release. This filing is primarily an announcement of these results, without detailing specific figures within the 8-K itself, but refers investors to the furnished press release (Exhibit 99.1) for comprehensive information. Investors should consult the press release for details on revenue, earnings, operational performance, and financial condition for the quarter ended September 30, 2019. The information furnished in this 8-K is not considered 'filed' for regulatory purposes such as Section 18 of the Exchange Act, meaning it doesn't carry the same legal implications as a formally filed document. However, it serves as the official notification of the company's performance during the third quarter and is a crucial point of reference for evaluating the company's ongoing business trajectory and market position.
Key Highlights
- 1Biogen Inc. reported its third-quarter 2019 financial results on October 22, 2019.
- 2The results were announced via a press release, furnished as Exhibit 99.1 to the 8-K filing.
- 3The 8-K filing itself does not contain detailed financial figures, directing investors to the press release for specific operational and financial condition information.
- 4The furnished information is not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.
- 5Investors are directed to Exhibit 99.1 for detailed quarterly performance data.
- 6This filing serves as an official announcement of the company's Q3 2019 performance.